Lv4
430 积分 2023-07-02 加入
[Cancer incidence and mortality in China, 2022]
3小时前
待确认
Thyroid Cancer
3小时前
已完结
Efficacy and safety of KRAS G12C inhibitor IBI351 monotherapy in patients with advanced non-small cell lung cancer: results from a phase 2 pivotal study
5个月前
已完结
Glioma
8个月前
已完结
Glioblastoma and Other Primary Brain Malignancies in Adults
8个月前
已完结
Glioma
8个月前
已完结
Revamping the innate or innate-like immune cell-based therapy for hepatocellular carcinoma: new mechanistic insights and advanced opportunities
8个月前
已完结
Low‐dose radiation therapy mobilizes antitumor immunity: New findings and future perspectives
10个月前
已完结
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non–Small Cell Lung Cancer Patients
10个月前
已完结
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial
10个月前
已完结
皖公网安备34019202002308
